AEGiS-IRIN: Activists Urge Government to Declare AIDS National Emergency

Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.

Activists Urge Government to Declare AIDS National Emergency

UN Integrated Regional Information Networks - September 21, 2001

Pharmaceutical leaders warn that AIDS research could dry up Representatives of the world's largest pharmaceutical companies warned that proposed amendments to the 1994 Trade-Related Intellectual Property Rights Agreement (TRIPS), that would make it easier for developing countries to produce generic forms of patented medicines, could cause pharmaceutical research and development into AIDS drugs to "dry up", Reuters reported on Thursday.

The warning was issued by delegates at the World Trade Organisation (WTO), in Geneva, Switzerland who met to discuss whether the TRIPS patents and copyright pact should be amended to make it easier for poor countries to get medicines at low cost. Under the TRIPS agreement, new drug patents are protected in the WTO's 142 member nations for 20 years. Following pressure from activists around the world demanding affordable treatment for poor people living with HIV/AIDS, the TRIPS Council of the WTO is holding its third meeting since June on drug access and intellectual property protection. A statement from Medecins Sans Frontieres on TRIPS and affordable medicines called upon WTO members to support developing countries' proposal to ensure that the multilateral rules on intellectual property do not harm public health.

"More flexibility in TRIPS would be disastrous for continuing investment in research and development on AIDS," Dr Rolf Krebs, chair of Boehringer Ingelheim and president of the International Federation of Pharmaceutical Manufacturers Associations, was reported as saying.
010921
IR010950

Copyright © 2001 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980 – 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .